Phreesia, Inc. (NYSE:PHR) Receives $16.65 Average Target Price from Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have received an average recommendation of “Hold” from the nineteen analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and nine have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $16.6471.

Several equities analysts have recently issued reports on PHR shares. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Truist Financial boosted their price objective on shares of Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a research note on Thursday, May 28th. DA Davidson restated a “buy” rating and issued a $14.00 price objective on shares of Phreesia in a report on Thursday, May 28th. Weiss Ratings raised Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, July 20th. Finally, Barclays reaffirmed an “equal weight” rating and set a $10.00 target price (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in PHR. Pale Fire Capital SE bought a new stake in Phreesia in the first quarter valued at approximately $72,481,000. BlackRock Inc. bought a new position in Phreesia during the 2nd quarter worth approximately $72,234,000. Granahan Investment Management LLC raised its holdings in Phreesia by 73.8% during the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after purchasing an additional 1,018,987 shares during the last quarter. Prosight Management LP acquired a new position in shares of Phreesia in the 4th quarter worth approximately $16,533,000. Finally, Millennium Management LLC lifted its position in shares of Phreesia by 730.7% in the 3rd quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after purchasing an additional 936,033 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Stock Performance

NYSE:PHR opened at $12.28 on Friday. The stock has a market cap of $758.78 million, a P/E ratio of 81.84 and a beta of 0.85. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The stock’s 50-day moving average is $10.52 and its 200-day moving average is $10.59. Phreesia has a 1-year low of $7.77 and a 1-year high of $32.76.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. During the same quarter in the prior year, the firm posted ($0.07) earnings per share. The firm’s revenue was up 12.9% compared to the same quarter last year. Equities research analysts anticipate that Phreesia will post 0.39 earnings per share for the current year.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.